Germany and U.S. Engage in Confidential Drug Price Talks

The German government has been in confidential negotiations with the U.S. Department of Health and Human Services concerning drug prices. These discussions are linked to U.S. President Donald Trump's demand for Germany and other European nations to pay higher prices for medications.

The German government has engaged in confidential negotiations with the U.S. Department of Health and Human Services regarding drug pricing, as reported by Politico. The discussions, ongoing for several months, involve German health and economic ministries alongside the U.S. administration.

The negotiations are a result of President Donald Trump's insistence that Germany and other European countries should pay higher prices for medicines, according to unnamed sources familiar with the matter.

The German health ministry declined to comment on these talks, and the U.S. Health and Human Services did not immediately respond to requests for comment from Reuters.